Showing results (81-90 of 123) with videos related to

Sort By:
Pageof 13
Annals of the Rheumatic Diseases|December 13, 2006
Treatment with TNF blockers and mortality risk in patients with rheumatoid arthritisLennart T H Jacobsson, Carl Turesson, Jan-Ake Nilsson, et al.
Rheumatology (Oxford, England)|May 14, 2011
Sick leave in patients with ankylosing spondylitis before and after anti-TNF therapy: a population-based cohort studyLars E Kristensen, Ingemar F Petersson, Pierre Geborek, et al.
BMC Musculoskeletal Disorders|August 7, 2013
Early increase in serum-COMP is associated with joint damage progression over the first five years in patients with rheumatoid arthritisMaria L E Andersson, Björn Svensson, Ingemar F Petersson, et al.
Primary Health Care Research & Development|January 15, 2020
Evaluation of a multimodal pain rehabilitation programme in primary care based on clinical register data: a feasibility studyCharlotte Post Sennehed, Kjerstin Stigmar, Birgitta Grahn, et al.
Rheumatology (Oxford, England)|December 20, 2015
Does disease activity at start of biologic therapy influence work-loss in RA patients?Tor Olofsson, Kari Johansson, Jonas K Eriksson, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|April 12, 2011
Sickness absence among cancer patients in the pre-diagnostic and the post-diagnostic phases of five common forms of cancerKatarina Sjövall, Bo Attner, Martin Englund, et al.
Lancet (London, England)|April 3, 2012
Conventional combination treatment versus biological treatment in methotrexate-refractory early rheumatoid arthritis: 2 year follow-up of the randomised, non-blinded, parallel-group Swefot trialRonald F van Vollenhoven, Pierre Geborek, Kristina Forslind, et al.
Annals of the Rheumatic Diseases|August 10, 2010
Decrease in sick leave among patients with rheumatoid arthritis in the first 12 months after start of treatment with tumour necrosis factor antagonists: a population-based controlled cohort studyTor Olofsson, Martin Englund, Tore Saxne, et al.
Annals of the Rheumatic Diseases|December 15, 2010
Predictors of response to methotrexate in early DMARD naive rheumatoid arthritis: results from the initial open-label phase of the SWEFOT trialSaedis Saevarsdottir, Helena Wallin, Maria Seddighzadeh, et al.
The Journal of Rheumatology|May 3, 2017
Severe Extraarticular Manifestations in a Community-based Cohort of Patients with Rheumatoid Arthritis: Risk Factors and Incidence in Relation to Treatment with Tumor Necrosis Factor InhibitorsLisa Theander, Britt-Marie Nyhäll-Wåhlin, Jan-Åke Nilsson, et al.
Pageof 13